Germany· DE-A57-85fbdabbcafb0cd5

Abirateron Sun

A abiraterone product containing abiraterone acetate, registered in Germany by Sun Pharmaceuticals Germany Gmbh. The same ATC class is registered in 18 of our 19 countries.

ATC L02BX03

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedAbirateron SunATCL02BX03REGISTER NO.DE-A57-85fbdabbcafb0c…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Abiraterone is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose

Abiraterone · ATC L02BX03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abiraterone costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Abiraterone · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$42.72
  • FR France$33.07
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Abiraterone Acetate
Manufacturer
Sun Pharmaceuticals Germany Gmbh
Country
Germany (DE)
ATC code
L02BX03
ATC class
Abiraterone
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for abiraterone.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Abiraterone · interactions on record

461 records

  • 101 severe
  • 335 moderate
  • 25 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • LoperamideA07DA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Abiraterone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abiraterone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Abiral, Abirateron +pharma
  • Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
  • Bulgaria · Абиратерон Msn, Абиратерон Деватис
  • Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
  • Czechia · Abirateron Ashcure, Abirateron Pharmagen
  • Denmark · Abirateron "olpha", Abirateron "sandoz"
  • Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Spain · Abiraterona Ashcure, Abiraterona Cipla
  • Finland · Abirateron Avansor, Abirateron Devatis
  • France · Abiraterone Acetate Zydus, Abiraterone Arrow
  • United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
  • Greece · Abinone, Abiprostem
  • Croatia · Abirateron Alpha-Medical, Abirateron Devatis
  • Hungary · Abaxan, Abirateron Galenika
  • Ireland · Abiraterone, Abiraterone Aristo
  • Iceland · Abirateron, Abirateron Medical Valley
  • Italy · Abiraterone Abdi, Abiraterone Abdi Farma
  • Liechtenstein · Abiraterone Accord, Abiraterone Mylan
  • Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Luxembourg · Abirateron Eg, Abiraterone Eugia
  • Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Malta · Abiraterone Ashcure, Abiraterone Clonmel
  • Netherlands · Abirateron 1a Pharma, Abirateron Abdi
  • Norway · Abirateron Devatis, Abirateron Medical Valley
  • Poland · Abiral, Abirateron Sun
  • Portugal · Abiraterona Bluepharma, Abiraterona Eugia
  • Romania · Abirateron? Lannacher, Abirateronă
  • Sweden · Abirateron Devatis, Abirateron Medical Valley
  • Slovenia · Abirateron Galenika, Abirateron Teva
  • Slovakia · Abirateron Msn, Abirateron Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e206e981-e4ac-4a81-928f-b7b724a35d8a
GET /v1/drugs/e206e981-e4ac-4a81-928f-b7b724a35d8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Abiraterone Acetate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about abiraterone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.